CD274 and neoplasm: The immunotherapy arm demonstrated better downsizing with a pT0 outcome of 23% in arm A and 15% in arm B. A pN0 resection was reached of 68% in arm A and 54% in arm B. Greater tumor regression was seen in arm A, with escalating levels of regression noted for higher PD-L1 scores.